BICO Group AB
OTC:CLLKF

Watchlist Manager
BICO Group AB Logo
BICO Group AB
OTC:CLLKF
Watchlist
Price: 2.46 USD
Market Cap: 169.9m USD

BICO Group AB
Net Income (Common)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

BICO Group AB
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
BICO Group AB
STO:BICO
Net Income (Common)
-kr5.5m
CAGR 3-Years
71%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
AddLife AB
STO:ALIF B
Net Income (Common)
kr252m
CAGR 3-Years
-29%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Net Income (Common)
kr255m
CAGR 3-Years
6%
CAGR 5-Years
5%
CAGR 10-Years
13%
G
Genovis AB
STO:GENO
Net Income (Common)
kr21.2m
CAGR 3-Years
-20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
MedCap AB (publ)
STO:MCAP
Net Income (Common)
kr196.9m
CAGR 3-Years
19%
CAGR 5-Years
30%
CAGR 10-Years
28%
M
Magle Chemoswed Holding AB
STO:MAGLE
Net Income (Common)
kr11.9m
CAGR 3-Years
42%
CAGR 5-Years
76%
CAGR 10-Years
N/A
No Stocks Found

BICO Group AB
Glance View

BICO Group AB is a bioconvergence company, which engages in the provision of technologies, products, and services to create, understand and master biology. The company is headquartered in Goeteborg, Vastra Gotalands and currently employs 890 full-time employees. The company went IPO on 2016-11-03. The firm focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The firm develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.

CLLKF Intrinsic Value
4.75 USD
Undervaluation 48%
Intrinsic Value
Price

See Also

What is BICO Group AB's Net Income (Common)?
Net Income (Common)
-5.5m SEK

Based on the financial report for Dec 31, 2024, BICO Group AB's Net Income (Common) amounts to -5.5m SEK.

What is BICO Group AB's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
71%

Over the last year, the Net Income (Common) growth was 100%. The average annual Net Income (Common) growth rates for BICO Group AB have been 71% over the past three years .

Back to Top